Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome

Shalini Shenoy, Susan Arnold, Talal Chatila

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

We report a child who developed autoimmune lymphoproliferative syndrome (ALPS) secondary to a heterozygous dominant negative mutation in the death domain of the Fas receptor. Previously developmentally normal, he had symptoms of autism with rapid regression in developmental milestones coincident with the onset of lymphoproliferation and autoimmune hemolytic anemia. Low-dose steroid therapy induced early and complete remission in the ALPS phenotype. There was subjective improvement, followed by objective improvement in speech and developmental milestones. We propose that autism may be part of the autoimmune disease spectrum of ALPS in this child, and this case represents a novel manifestation and target organ involvement in this disease.

Original languageEnglish (US)
Pages (from-to)682-687
Number of pages6
JournalJournal of Pediatrics
Volume136
Issue number5
StatePublished - 2000

Fingerprint

Autoimmune Lymphoproliferative Syndrome
Autistic Disorder
Steroids
CD95 Antigens
Autoimmune Hemolytic Anemia
Death Domain Receptors
Autoimmune Diseases
Therapeutics
Phenotype
Mutation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome. / Shenoy, Shalini; Arnold, Susan; Chatila, Talal.

In: Journal of Pediatrics, Vol. 136, No. 5, 2000, p. 682-687.

Research output: Contribution to journalArticle

@article{782be20ac92b4944b4ed1e630ed2f8a2,
title = "Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome",
abstract = "We report a child who developed autoimmune lymphoproliferative syndrome (ALPS) secondary to a heterozygous dominant negative mutation in the death domain of the Fas receptor. Previously developmentally normal, he had symptoms of autism with rapid regression in developmental milestones coincident with the onset of lymphoproliferation and autoimmune hemolytic anemia. Low-dose steroid therapy induced early and complete remission in the ALPS phenotype. There was subjective improvement, followed by objective improvement in speech and developmental milestones. We propose that autism may be part of the autoimmune disease spectrum of ALPS in this child, and this case represents a novel manifestation and target organ involvement in this disease.",
author = "Shalini Shenoy and Susan Arnold and Talal Chatila",
year = "2000",
language = "English (US)",
volume = "136",
pages = "682--687",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome

AU - Shenoy, Shalini

AU - Arnold, Susan

AU - Chatila, Talal

PY - 2000

Y1 - 2000

N2 - We report a child who developed autoimmune lymphoproliferative syndrome (ALPS) secondary to a heterozygous dominant negative mutation in the death domain of the Fas receptor. Previously developmentally normal, he had symptoms of autism with rapid regression in developmental milestones coincident with the onset of lymphoproliferation and autoimmune hemolytic anemia. Low-dose steroid therapy induced early and complete remission in the ALPS phenotype. There was subjective improvement, followed by objective improvement in speech and developmental milestones. We propose that autism may be part of the autoimmune disease spectrum of ALPS in this child, and this case represents a novel manifestation and target organ involvement in this disease.

AB - We report a child who developed autoimmune lymphoproliferative syndrome (ALPS) secondary to a heterozygous dominant negative mutation in the death domain of the Fas receptor. Previously developmentally normal, he had symptoms of autism with rapid regression in developmental milestones coincident with the onset of lymphoproliferation and autoimmune hemolytic anemia. Low-dose steroid therapy induced early and complete remission in the ALPS phenotype. There was subjective improvement, followed by objective improvement in speech and developmental milestones. We propose that autism may be part of the autoimmune disease spectrum of ALPS in this child, and this case represents a novel manifestation and target organ involvement in this disease.

UR - http://www.scopus.com/inward/record.url?scp=0034031686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034031686&partnerID=8YFLogxK

M3 - Article

VL - 136

SP - 682

EP - 687

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 5

ER -